London Daily

Focus on the big picture.
Wednesday, Feb 11, 2026

Oxford Covid vaccine could be approved 'just after Christmas'

Oxford Covid vaccine could be approved 'just after Christmas'

The coronavirus vaccine being developed by Oxford University and AstraZeneca could be approved shortly after Christmas, a medical scientist has said.


Professor Sir John Bell said he expects the Medicines and Healthcare products Regulatory Agency (MRHA) to sign off its approval of the jab ‘pretty shortly’.

Sir John, Oxford University’s regius professor of medicine, told BBC Radio 4’s Today programme: ‘They got data quite a long time ago but that was the first set of data. They receive multiple sets of data.

‘So we are getting to be about prime time now, I would expect some news pretty shortly. I doubt we’ll make Christmas now, but just after Christmas I would expect. I have no concerns whatsoever that the data looks better than ever.’

His comments came as former prime minister Tony Blair called for major policy shifts in the rollout of vaccines, concentrating on giving more people a single dose with greater flexibility in who receives a jab.

Approval of the Oxford vaccine would be a major boost to efforts to control Covid-19 because it is easier to distribute than the Pfizer/BioNTech jab currently being used in the UK.


Approval from regulators is expected shortly after Christmas


The Government has ordered 100 million doses of the Oxford/AstraZeneca vaccine, with around 40 million available by the end of March.

Health Secretary Matt Hancock told a Downing Street press conference that the Oxford/AstraZeneca team has now submitted full data to the regulator for approval.

He said: ‘This is the next step towards a decision on the deployment of the vaccine which is already being manufactured, including here in the UK.’


The Government has ordered 100 million doses of the Oxford/AstraZeneca vaccine


Mr Blair told Today ‘the reality is we are now in severe lockdown until vaccination’ and so it should be a priority to give as many people as possible some protection.

While ideally people should received the required two doses, the question is: ‘Does the first dose give you substantial immunity, and by that I mean over 50% effectiveness?

‘If it does, there is a very strong case for not, as it were, holding back doses of the vaccine.’


A volunteer is administered the coronavirus vaccine developed by AstraZeneca and Oxford University


For example ‘if, in January, AstraZeneca is delivering you 10 or 20 million doses of the vaccine, you vaccinate 10 or 20 million people’.

Mr Blair went on: ‘You should get more vaccine coming on stream by the time you are ready for the second dose and that first dose can give you substantial immunity.’

The former premier also criticised the ‘somewhat inflexible “by age” structure’ used to determine who receives the jab.


A vial of coronavirus vaccine developed by AstraZeneca and Oxford University


Experts at the Joint Committee on Vaccination and Immunisation have drawn up a priority list based on clinical need.

But Mr Blair, who does not have a medical background, said ‘there is a strong case for saying you have got to focus also on the people spreading the disease, not simply the most vulnerable’.

Communities Secretary Robert Jenrick told Today that the Government is focusing on getting as many people as possible to receive the first dose of the Pfizer vaccine.

He said: ‘At the moment the priority is just to ensure that as many people as possible get the first shot of the vaccine.

‘Remember, the second shot has to be done, depending on what the vaccine is, 21 or 28 days later and so we still haven’t reached that point with the first people who were vaccinated.’

Asked whether the Government would consider dropping the second shot, Mr Jenrick said: ‘The strategy will always be kept under review but the priority today is to ensure that as many people as possible are given the first shot of the vaccine; that is what is happening.’

Newsletter

Related Articles

0:00
0:00
Close
Heineken announces cut of 6,000 jobs due to declining beer demand
Beijing Brands UK Hong Kong Visa Expansion ‘Despicable and Reprehensible’ After Jimmy Lai Sentencing
Tesco Chief Warns UK Is ‘Sleepwalking’ Toward a Joblessness Crisis
Trump’s ‘Act of Great Stupidity’ Comment on UK Chagos Deal Reverberates Through Diplomacy and Strategy
New U.S. filings say Jeffrey Epstein repaid Les Wexner one hundred million dollars after theft allegation
Commerce Secretary Howard Lutnick acknowledges 2012 visit to Jeffrey Epstein’s private island as lawmakers scrutinise past ties
Helsing and Stark Defence loitering-munition drones and Germany’s race to industrialise battlefield autonomy
UK orders deletion of Courtsdesk court-data archive, reigniting the fight over who controls public justice records
UK Police Review Fresh Claims Involving Prince Andrew as Senior Royals Respond to Epstein Files
Keir Starmer’s Premiership Faces Unprecedented Strain as Epstein Fallout Deepens
Starmer Vows to Stay in Office as UK Government Faces Turmoil After Epstein Fallout
China and UK Signal Tentative Reset with Commitment to Steadier, Professionally Managed Relations
UK Confirms Imminent Increase in ETA Fee to £20 as Entry Rules Tighten
UK Signals Possible Seizure of Russia-Linked ‘Shadow Fleet’ Tanker in Escalation of Sanctions Enforcement
Epstein Scandal Piles Unprecedented Pressure on UK Prime Minister Keir Starmer’s Leadership
UK’s ‘Most Romantic Village’ Celebrates Valentine’s Day and Explores the Festival’s Rich History
The Implications of Expanding Voting Rights to Non-EU Foreign Residents in France
Ghislaine Maxwell to Testify Before US Congress on February 9
Al.com Acquired by Crypto.com Founder for $70 Million
Apple iPhone Lockdown Mode blocks FBI data access in journalist device seizure
Belgium: Man Charged with Rape After Faking Payment to Sex Worker
KPMG Urges Auditor to Relay AI Cost Savings
US and Iran to Begin Nuclear Talks in Oman
Winklevoss-Led Gemini to Slash a Quarter of Jobs and Exit European and Australian Markets
Canada Opens First Consulate in Greenland Amid Rising Geopolitical Tensions
China unveils plans for a 'Death Star' capable of launching missile strikes from space
NASA allows astronauts to take smartphones on upcoming missions to capture special moments.
Trump administration to launch TrumpRx.gov for direct drug purchases
Investigation Launched at Winter Olympics Over Ski Jumpers Injecting Hyaluronic Acid
U.S. State Department Issues Urgent Travel Warning for Citizens to Leave Iran Immediately
Wall Street Erases All Gains of 2026; Bitcoin Plummets 14% to $63,000
Epstein Case Documents Reignite Global Scrutiny of Political and Business Elites
Eighty-one-year-old man in the United States fatally shoots Uber driver after scam threat
UK Royal Family Faces Intensifying Strain as Epstein-Linked Revelations Rock the Institution
Political Censorship: French Prosecutors Raid Musk’s X Offices in Paris
AI Invented “Hot Springs” — Tourists Arrived and Were Shocked
Tech Mega-Donors Power Trump-Aligned Fundraising Surge to $429 Million Ahead of 2026 Midterms
UK Pharma Watchdog Rules Sanofi Breached Industry Code With RSV Vaccine Claims Against Pfizer
Melania Documentary Opens Modestly in UK with Mixed Global Box Office Performance
Starmer Arrives in Shanghai to Promote British Trade and Investment
Harry Styles, Anthony Joshua and Premier League Stars Among UK’s Top Taxpayers
New Epstein Files Include Images of Former Prince Andrew Kneeling Over Unidentified Woman
Starmer Urges Former Prince Andrew to Testify Before US Congress About Epstein Ties
Starmer Extends Invitation to Japan’s Prime Minister After Strategic Tokyo Talks
Skupski and Harrison Clinch Australian Open Men’s Doubles Title in Melbourne
DOJ Unveils Millions of Epstein Files, Fueling Global Scrutiny of Elite Networks
France Begins Phasing Out Zoom and Microsoft Teams to Advance Digital Sovereignty
China Lifts Sanctions on British MPs and Peers After Starmer Xi Talks in Beijing
Trump Nominates Kevin Warsh as Fed Chair to Reorient U.S. Monetary Policy Toward Pro-Growth Interest Rates
AstraZeneca Announces £11bn China Investment After Scaling Back UK Expansion Plans
×